NCT00760019View on ClinicalTrials.gov

Inflammation and Vascular Function in Atherosclerosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

February 28, 2011

Conditions
Atherosclerosis
Interventions
DRUG

salsalate

1.5 grams orally 3 times daily

DRUG

placebo

matching placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT00760019 - Inflammation and Vascular Function in Atherosclerosis | Biotech Hunter | Biotech Hunter